medicaldevices

  Market Scenario: The most common causes of infertility include deficiencies in semen or egg production such as poor quality and sperm motility, lower hormonal levels, abnormal ejaculation and even psychological conditions. As per Market Research Future (MRFR)’s analysis, the market for  Infertility Market  stood at 11.2 billion in 2016, and is projected to expand at a CAGR of 4.6 % during the forecast period ending 2023. Market Dynamics: Rise In Risk Factors Is The Prime Reason For Market Growth The increase in risk factors for the global infertility market is sedentary lifestyles, increasing age at marriage, substance abuse, environmental factors, genetic abnormalities, stress, obesity, prostate cancer, varicocele, and others. Smoking, alcohol, anabolic steroid use, and illicit drug use is positively correlated to the growth of infertility. Cancer treatment such as chemotherapy, radiation, also affects fertility. Late marriage and hormonal disorders are other causes associated with

  Market Highlights: Acknowledging the kind of accruals, this market is garnering at present; Market Research Future (MRFR) in its recently published study report confirms that the global  Organ Preservation Market  will grow exponentially by 2023, posting a CAGR of approximately 8% during the forecast period of 2018–2023. Organ preservation as the name suggests refers to the preservation of various healthy organs harvested from deceased or alive donors. Organ preservation processes are just not limited to the preservation of successfully achieved organs, but these also ensure the feasibility and viability of these organs after prolonged ischemia. Usually, the devices used in organ preservation process ensure controlled temperature and regulated metabolites to impede harvested organs’ metabolism. Additionally, fluids that would be constantly pumped would ensure that these organs remain alive and active, even when on the move. Such preserved organs are later used for various transplant

  The market in Asia Pacific is expected to grow rapidly in the coming years. Based on a detailed study and analysis, it is found that this region has a good growth potential due to the increasing unhealthy eating habits and unhygienic conditions. Major factors driving the market are increasing geriatric population and increasing healthcare expenditure. On the other hand, low awareness in developing and underdeveloped regions regarding ophthalmic diseases may hamper the market growth during the forecast period.  Segmentation The global  Ophthalmic Equipment Market  is segmented on the basis of product, application, and end-user. On the basis of product, the market is segmented into vision care devices, ophthalmology surgical devices, diagnostic and monitoring devices, and others. Vision care devices a segmented into spectacles and contact lens. Contact lenses are further segmented into soft contact lenses, Rigid Gas Permeable lenses (RGP), and hybrid contact lenses. Ophthalmology surgi

  Overview: The recent report by Market Research Future (MRFR) predicts the global  Anti-Venom Market  value will be expanding with a healthy CAGR of 6.5% over the forecast period (2017–2023). Biotechnology, as well as the healthcare industry, is noting a considerable demand from developing nations globally. The prominent reason behind the strong growth of the anti-venom market is the growing demand for anti-venom treatment, as it is the only authorized treatment for snake bite, without any alternative treatment available. Moreover, violation of forest lands for housing and agricultural needs has gotten humans close to poisonous animals and insects, thereby increasing the prevalence of venomous bites. In addition, the prevalence of snake bites, scorpion bites, as well as other animal or insect bites like fish stings is an additional factor playing a major role in the anti-venom market growth. Various research and development (R&D) activities taking place continuously that provide a

  Market Highlights Increasing adoption of Electronic Health Record (EHR)/ Electronic Medical Record (EMR), rising prevalence of chronic diseases like diabetes, cancer, besides others followed by a dearth of physicians in the presence of increasing healthcare services demands drives the global telemedicine market. However, the high cost of implementing telemedicine systems and the need for training along with stringent government regulations is estimated to restraint the market growth during the projected period. Global  Telemedicine Market  is expected to grow at a CAGR of 16.8% and reach USD 56,738.3 by 2023. Segmentation The global telemedicine market is segmented on the basis of service type, component, deployment, application, and end user. On the basis of the service type, the market is segmented into telenursing, telepharmacy, teleradiology, teledermatology, teleoncology, others. On the basis of the component, the market is categorized into software and hardware. The software se

  Market Research Future published a half cooked research report on “Global   Advanced Cardiovascular Life Support Market   Research Report – Forecast to 2024– Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2024. CPR Medical Devices, Inc. (Canada), Cardiac Science Corporation (US), General Electric Company (US), Koninklijke Philips N.V. (Netherlands), Michigan Instruments (US), Physio-Control, Inc. (US), St. Jude Medical, Inc. (US), Asahi Kasei Corporation (Japan) and others are some of the major players in the Global Advanced Cardiovascular Life Support Market. Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/711 Global Advanced Cardiovascular Life Support Market – Overview Advanced cardiovascular life support is also referred as advanced cardiac life support is a set of clinical interventions for the emergency treatment of stroke and other life-threatening medical emergencies. According to WHO, more than 35% of the total global popul

  The global  Stem Cell Assay Market  2020, according to MRFR, is expected to witness substantial growth over the review period. Market Highlights Stem cell assays are an integral aspect of the field of biotechnology, which is increasing. The prevalence of chronic and various lifestyle disorders has forced drug research efforts to intensify in an attempt to create innovative therapies. Diseases like cancer and diabetes are on the increase at fast levels, and demand for safer, more effective, and more affordable drugs is pushing the industry towards expansion. Global health care spending is growing, and demand growth is strongly supported by developments in biotechnology and other medical innovations. Policy funding to the production of medications for chronic disorders has expanded work into stem cell assays. Strict regulatory regulations related to drug clearance, as well as high clinical costs of stem cell assays, hold the industry hostage. Also, there is a lack of knowledge about st

   The Americas region is responsible for the largest market share of the global  Metabolic Biomarker Testing Market  owing to the rising incidence of genetic abnormalities, governmental support for the research and development, and presence of sophisticated infrastructure. Moreover, North America is anticipated to dominate the market over the forecast period. This growth can be imputed to the rising disposable income of the population and increasing demand for personalized medicine of global metabolic biomarker market for the next few years. The European market has boost the market growth owing to the rising awareness about nutritional products, increasing numbers of clinical trials, and rapid growth of data analysis software for metabolic biomarker are the factors to propel the growth of this market. The U.K contributed to huge market share followed by Germany and Italy owing to a huge patient population in Europe. Asia Pacific is witnessing the fastest growth in the global metabolic

  Market Highlights: E-prescribing systems is a technology for generating and transmitting prescription from medical professionals to pharmacists electronically. E-prescribing systems serves as an electronic reference handbook. It allows the physician to send prescriptions directly from the point of care. The Global  E-prescribing systems Market  is expected to grow at a CAGR of 21% during the forecast period. Regional Analysis The Americas dominate the global e-prescribing systems market owing to the rising government initiatives and funding. North America holds the largest market share owing to increasing adoption of healthcare management software’s, increasing government initiatives, and extensive use of healthcare IT for patient engagement and administration. Additionally, the mandatory implementation of E-Health Record (EHR), and expansion of Healthcare IT in hospitals and clinics are propelling the growth of this market. For instance, the Medicare and Medicaid EHR Incentive Progr

   Market Research Future published a half-cooked research report on global  Multiple Sclerosis Treatment Market . The global multiple sclerosis treatment market is expecting a steady growth in the near future owing to increasing prevalence of muscle weakness related problems and increasing elderly population. Multiple sclerosis has no permanent cure and can be diagnosed and treated, which can reduce the progression of MS. The increasing patient population, greater screening, and need for better treatment options are major factors for growth of this market during forecasted period. The disease is more common in aging population. Which is likely to boost the growth of the market. Nevertheless, the significant gap between early diagnosis and the actual initiation of therapy remains a critical restraining factor to market growth. The lack of cure and effective treatment is a major drawback of the current treatment. Advent of a new drug with even partial cure rates will be welcomed by the

  Market Highlights It is estimated that  Diabetes Monitors Market  is expected to grow at a CAGR 8.3% during the forecast period 2017-2023. Diabetes is a metabolic disease that occurs when blood glucose level is too high either due to inadequate insulin production or because of low response towards insulin. The three most common type of diabetes are Type 1, Type 2, and gestational diabetes. Other less common type includes cystic fibrosis-related diabetes, and monogenic diabetes. The frequent blood glucose monitoring is critical for diabetic management, as the maintenance of standard glucose level, i.e. 4–8 mM, is the only way that a diabetic person can lead a healthy lifestyle. According to WHO, global prevalence of diabetes has risen from 4.7% to 8.5% in 2014. It is also estimated that around 1.6 million deaths have occurred in 2015 due to diabetes worldwide. Rise in technological innovations, huge research funding for diabetes diagnosis and treatment, increasing prevalence and incid

   As per the latest report published by Market Research Future (MRFR) the global market for  In-Vitro Diagnostics Market  will record a CAGR of 8.16% between 2018 and 2023. The market is expected to surpass a valuation of USD 102,500 Mn by the end of the assessment period. In-vitro diagnostics (IVD) combines the application of reagents, medical devices and accessories for performing complex test procedures on biological specimens such as tissue, blood and urine taken from human body. In-vitro diagnostics is increasingly used for diagnosis of medical conditions and detection of infection. IVD has emerged as an important medical technology for overcoming challenges faced in diagnosis and management of diseases. Such factors are supporting the growth of the global IVD market. IVD is more precise than conventional test procedures and thereby gaining a quick popularity. In fact, many of the modern test procedures cannot be carried out without using IVD technology. Medical diagnostic device